Penumbra Inc (PEN) stock
PENNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/3074% above fair value
$320.62−0.29 (-0.09%)
Close on Nov 16, 2026Market cap $12.64BP/E 80.8Yield –
Penumbra enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Penumbra's enterprise value was $12.04B on Nov 11, 2026, against $11.16B a year earlier. Over the last 5 years it ranged from $4.47B to $13.74B, with a median of $9.61B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $12.04B | +1.5% |
| 2025 | Dec 31, 2025 | $11.86B | +31.7% |
| 2024 | Dec 31, 2024 | $9.01B | -6.0% |
| 2023 | Dec 29, 2023 | $9.59B | +16.0% |
| 2022 | Dec 30, 2022 | $8.26B | -21.4% |
| 2021 | Dec 31, 2021 | $10.51B | +68.8% |
| 2020 | Dec 31, 2020 | $6.23B | +6.7% |
| 2019 | Dec 31, 2019 | $5.84B | +35.9% |
| 2018 | Dec 31, 2018 | $4.29B | +41.8% |
| 2017 | Dec 29, 2017 | $3.03B | +44.5% |
| 2016 | Dec 30, 2016 | $2.10B | +44.7% |
| 2015 | Dec 31, 2015 | $1.45B | – |
See a number that looks wrong?